Inventor
MACIELAG MARK J
US56 patents
⚠️ This page may combine multiple inventors who share the name “MACIELAG MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
26 patentsUS8759333B2Jun 24, 2014
Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV45 citations94
US8685990B2Apr 1, 2014
Pyrimidine compounds as delta opioid receptor modulators
JANSSEN PHARMACEUTICA NV19 citations92
US8748417B2Jun 10, 2014
Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV9 citations84
US7179805B2Feb 20, 2007
7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JANSSEN PHARMACEUTICA NV15 citations80
US11230526B1Jan 25, 2022
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors
JANSSEN PHARMACEUTICA NV2 citations72
US8697683B2Apr 15, 2014
Azetidinyl diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV2 citations72
US12545677B2Feb 10, 2026
Compounds useful as factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations61
US8378117B2Feb 19, 2013
Hexahydro-cycloheptapyrazole cannabinoid modulators
JANSSEN PHARMACEUTICA NV2 citations61
US7183445B2Feb 27, 2007
Cyclohexyl derivatives as selective estrogen receptor modulators
JANSSEN PHARMACEUTICA NV2 citations61
US7732612B2Jun 8, 2010
7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JANSSEN PHARMACEUTICA NV3 citations60
US6825172B2Nov 30, 2004
3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
JANSSEN PHARMACEUTICA NV2 citations58
US12286429B2Apr 29, 2025
5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations52
US9636345B2May 2, 2017
Benzimidazole derivatives useful TRPM8 channel modulators
JANSSEN PHARMACEUTICA NV0 citations52
US8981113B2Mar 17, 2015
Benzimidazole derivatives useful as TRPM8 channel modulators
JANSSEN PHARMACEUTICA NV0 citations52
US8759533B2Jun 24, 2014
Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
JANSSEN PHARMACEUTICA NV1 citations52
US10118900B2Nov 6, 2018
Benzimidazole derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV1 citations51
US9067935B2Jun 30, 2015
Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9434711B2Sep 6, 2016
Sulfonamides as TRPM8 modulators
JANSSEN PHARMACEUTICA NV0 citations49
US11814364B2Nov 14, 2023
Pyridine N-oxide derivatives useful as factor XIa inhibitors
JANSSEN PHARMACEUTICA NV0 citations48
US8987247B2Mar 24, 2015
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
JANSSEN PHARMACEUTICA NV0 citations46
US7776855B2Aug 17, 2010
Antimicrobial oxazolidinone prodrugs
JANSSEN PHARMACEUTICA NV1 citations44
US10590083B2Mar 17, 2020
Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations42
US10399944B2Sep 3, 2019
Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations42
US10336701B2Jul 2, 2019
Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations42
US9815790B2Nov 14, 2017
Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV0 citations41
US9682940B2Jun 20, 2017
Indazole derivatives useful as CB-1 inverse agonists
JANSSEN PHARMACEUTICA NV0 citations41
ORTHO MCNEIL PHARM INC
6 patentsUS6492358B2Dec 10, 2002
β-carboline derivatives useful as inhibitors of phosphodiesterase
ORTHO MCNEIL PHARM INC37 citations93
US6635638B2Oct 21, 2003
Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
ORTHO MCNEIL PHARM INC31 citations92
US6077841AJun 20, 2000
5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
ORTHO MCNEIL PHARM INC22 citations92
US6809107B1Oct 26, 2004
Neurotrophic pyrrolidines and piperidines, and related compositions and methods
ORTHO MCNEIL PHARM INC5 citations62
US6583179B2Jun 24, 2003
Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
ORTHO MCNEIL PHARM INC6 citations61
US6713455B2Mar 30, 2004
6-O-carbamate-11,12-lacto-ketolide antimicrobials
ORTHO MCNEIL PHARM INC3 citations59
OHMEDA PHARMA PROD
4 patentsUS5470830ANov 28, 1995
Motilin-like polypeptides that inhibit gastrointestinal motor activity
OHMEDA PHARMA PROD37 citations88
US5494898AFeb 27, 1996
Peptide skeletal muscle relaxants
OHMEDA PHARMA PROD15 citations73
US5422341AJun 6, 1995
Motilin-like polypeptides with gastrointestinal motor stimulating activity
OHMEDA PHARMA PROD16 citations67
US5734012AMar 31, 1998
Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
OHMEDA PHARMA PROD12 citations65
CONNOLLY PETER J
4 patentsUS8513423B2Aug 20, 2013
Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
CONNOLLY PETER J8 citations83
US8183371B2May 22, 2012
Pyrazines as delta opioid receptor modulators
CONNOLLY PETER J2 citations62
US8637498B2Jan 28, 2014
Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
CONNOLLY PETER J2 citations61
US8293750B2Oct 23, 2012
Pyrazines as delta opioid receptor modulators
CONNOLLY PETER J0 citations51
BRANUM SHAWN T
2 patentsCOATS STEVEN J
2 patentsMACIELAG MARK J
2 patentsORTH MCNEIL PHARMACEUTICAL INC
1 patent(unassigned)
1 patentZHANG YUE-MEI
1 patentJETTER MICHELE C
1 patentShowing the top 50 of 56 patents by PatentIndex Score.